Shinya Yamanaka
MD, PhD
Director and Professor
👥Biography 个人简介
Shinya Yamanaka received the Nobel Prize in Physiology or Medicine in 2012 for discovering that mature cells can be reprogrammed to become pluripotent stem cells, a breakthrough that created the entire field of iPSC-derived cell therapy. At Kyoto University's CiRA, he has established the world's first clinical-grade iPSC stock from HLA-homozygous donors to provide immunologically compatible cells for allogeneic applications. His ongoing work focuses on expanding the iPSC stock to cover major HLA haplotypes and advancing iPSC-derived products into clinical trials for cancer and other diseases.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Shinya Yamanaka 的研究动态
Follow Shinya Yamanaka's research updates
留下邮箱，当我们发布与 Shinya Yamanaka（Center for iPS Cell Research and Application, Kyoto University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment